uu.seUppsala University Publications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Pharmacokinetic and Pharmacokinetic/ Pharmacodynamic Modeling to Inform Optimal Dose of Vorapaxar
Merck & Co Inc, Kenilworth, NJ USA..
Merck & Co Inc, Kenilworth, NJ USA..
Merck & Co Inc, Kenilworth, NJ USA..
Merck & Co Inc, Kenilworth, NJ USA..
Show others and affiliations
2015 (English)In: Journal of Pharmacokinetics and Pharmacodynamics, ISSN 1567-567X, E-ISSN 1573-8744, Vol. 42, no S1, S103-S103 p.Article in journal, Meeting abstract (Other academic) Published
Resource type
Text
Place, publisher, year, edition, pages
2015. Vol. 42, no S1, S103-S103 p.
National Category
Pharmacology and Toxicology
Identifiers
URN: urn:nbn:se:uu:diva-280819ISI: 000367842000201OAI: oai:DiVA.org:uu-280819DiVA: diva2:915476
Conference
The American Conference on Pharmacometrics 2015 (ACoP6), October 3 to 8, 2015, Virginia, USA
Note

Meeting Abstract: W-62

Available from: 2016-03-30 Created: 2016-03-15 Last updated: 2017-11-30Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Karlsson, Mats

Search in DiVA

By author/editor
Karlsson, Mats
By organisation
Department of Pharmaceutical Biosciences
In the same journal
Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology and Toxicology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 502 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf